Trade Rules, Intellectual Property, and the Right to Health [Abstract]

Ethics & International Affairs, Volume 21.3 (Fall 2007)

In perpetuating and exacerbating restricted access to essential medicines, current trade-related intellectual property rules on medicines may violate core human rights to health and medicines. In this light, there should be serious questions about their necessity, and their justification should be critically assessed from the perspective of human rights standards. These standards require that international trade rules on medicines be justified to the fullest extent possible, and permitted only to the extent to which they can be justified.

In this article I explore the impact of trade rules on medicines access, and the growing force of the human right to health. I argue that the limited justification for strong patents in poor countries suggests the need for significant reform of trade-related intellectual property rights. I argue further that human rights standards may offer both normative and practical tools for achieving this reform and challenging trade rules on medicines at various levels.

To read or purchase the full text of this article, click here.

Read More: Health, Poverty, Justice, Global Public HealthHuman Rights, International Law, International Trade,

blog comments powered by Disqus
Search Our Site

People  |  Advanced Search

Join our Mailing Lists
Online Magazine

Online Magazine

Social Network

Social Network

The Journal

The Journal